US Patent Family Members and Approved Drugs for South Africa Patent: 866412
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Africa Patent: ZA866412
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 4,810,643 | 2006-03-07 | filgrastim | Amgen, Inc. | NEUPOGEN |
| 4,999,291 | 2005-08-23 | filgrastim | Amgen, Inc. | NEUPOGEN |
| 5,580,755 | 2013-12-03 | filgrastim | Amgen, Inc. | NEUPOGEN |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
